E134: Brepocitinib in Dermatomyositis (VALOR)
Apr 17, 2026 - 14:58
Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsReally interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzepatide to ixekizumab alone. Raises some interesting questions about what worked here and whether or not it matters h...
E135: IL17 and a GLP1? is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzepatide to ixekizumab alone. Raises...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Apr 30, 2026, 11:03 long, audio available.
Continue listening to more episodes from The Evidence Based Rheumatology Podcast.
Apr 17, 2026 - 14:58
Mar 19, 2026 - 15:21
Mar 5, 2026 - 13:54
Jan 21, 2026 - 14:48
Dec 22, 2025 - 13:06
Dec 4, 2025 - 15:17
Nov 12, 2025 - 19:03
Sep 22, 2025 - 21:46